Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.

From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

Weight-loss drug users were less likely to suffer many common addictions including to alcohol, cannabis, cocaine, nicotine, ...

‘Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study’ by Miao Cai et al. was published in The BMJ at 23:30 hours UK time ...

Substance use disorder makes it hard to stop using substances even when they're harmful. Using the term "substance use disorder" helps separate the person from the treatable illness. Substance use ...

Since President Donald Trump issued a July 2025 executive order aimed at "ending crime and disorder on America's streets," national attention has increasingly focused on involuntary treatment as a ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some patients to seek pain relief from substance use.

Researchers say the study provides insight into how early biological stress shapes addictive behaviors and identifies a ...

Dentistry has long been built on preventive care. It’s time to extend that preventive mindset to substance use.

Polysubstance use disorder is a mental health condition in which someone uses more than one substance at the same time or within a short period of time, despite a pattern of negative effects.

Addiction is an umbrella term that reflects qualities of substance use disorder, characterized by an inability to stop using a substance despite harmful consequences. However, addiction is not a ...